Edwards Lifesciences CorporationEWNYSE

Overview Intelligence Charts News Fundamentals

Analyst Sentiment

Analysts lean bullish — 75% recommend buying.

Consensus Rating

Buy

20 analysts·High coverage

75%

Rating Distribution

Strong Buy

00%

Buy

1575%

Hold

525%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 13% higher.

Bear Case

$87.00

+2%

Consensus

$96.38

+13%

Bull Case

$110.00

+29%

Price Range20 analysts

Low

Consensus

High

$87.00

$110.00

Current Target

Current Price

$85.28

Upside to Target

$11.10

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$2.97(17 analysts)

P/E46x

Current: 46.3x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+9.82%

EPS+11.81%

FY2028

Rev+9.96%

EPS+12.44%

FY2029

Rev+10.12%

EPS+12.61%

Earnings Surprises

Beat rate:75%(9/12 quarters)

Avg surprise:+3.0%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Feb 11, 2026Truist Financial

Edwards Lifesciences price target lowered to $89 from $92 at Truist

Target:$89.00

+15.8%from $76.85

Feb 11, 2026Goldman Sachs

Edwards Lifesciences price target lowered to $95 from $108 at Goldman Sachs

Target:$95.00

+23.3%from $77.05

Feb 11, 2026Piper Sandler

Edwards Lifesciences price target raised to $100 from $98 at Piper Sandler

Target:$100.00

+29.8%from $77.05

Feb 4, 2026UBS

Edwards Lifesciences price target lowered to $94 from $95 at UBS

Target:$94.00

+15.2%from $81.63

Jan 20, 2026Stifel Nicolaus

Edwards Lifesciences price target raised to $110 from $105 at Stifel

Target:$110.00

+30.4%from $84.35

Jan 20, 2026Piper Sandler

Edwards Lifesciences price target raised to $98 from $95 at Piper Sandler

Target:$98.00

+16.2%from $84.35

Jan 12, 2026UBS

Edwards Lifesciences price target raised to $95 from $92 at UBS

Target:$95.00

+13.7%from $83.58

Jan 12, 2026Robert W. Baird

Edwards Lifesciences price target raised to $90 from $87 at Baird

Target:$90.00

+7.5%from $83.69

Jan 12, 2026Barclays

Edwards Lifesciences price target raised to $104 from $103 at Barclays

Target:$104.00

+22.2%from $85.13

Jan 9, 2026Goldman Sachs

Edwards Lifesciences price target raised to $108 from $104 at Goldman Sachs

Target:$108.00

+27.7%from $84.58

Jan 7, 2026Stifel Nicolaus

Edwards Lifesciences price target raised to $105 from $100 at Stifel

Target:$105.00

+22.3%from $85.85

Jan 5, 2026Evercore ISI

Edwards Lifesciences price target raised to $94 from $92 at Evercore ISI

Target:$94.00

+11.4%from $84.34

Dec 18, 2025Wells Fargo

JPMorgan Upgrades Edwards Lifesciences (EW) to Overweight

Target:$100.00

+17.9%from $84.84

Dec 17, 2025Canaccord Genuity

Edwards Lifesciences price target lowered to $87 from $89 at Canaccord

Target:$87.00

+2.0%from $85.32

Dec 16, 2025Robert W. Baird

Edwards Lifesciences price target lowered to $87 from $88 at Baird

Target:$87.00

+4.3%from $83.38

Dec 8, 2025Barclays

Edwards Lifesciences price target raised to $103 from $99 at Barclays

Target:$103.00

+19.5%from $86.19

Dec 5, 2025UBS

Edwards Lifesciences price target raised to $92 from $90 at UBS

Target:$92.00

+6.3%from $86.58

Dec 5, 2025RBC Capital

Edwards Lifesciences (EW) PT Raised at RBC Capital; 'A Catalyst Rich Year in 2026 and Beyond'

Target:$100.00

+14.5%from $87.33

Dec 5, 2025Robert W. Baird

Edwards Lifesciences price target raised to $88 from $83 at Baird

Target:$88.00

+2.6%from $85.78

Dec 5, 2025Canaccord Genuity

Edwards Lifesciences price target raised to $89 from $84 at Canaccord

Target:$89.00

+3.8%from $85.78

Dec 5, 2025Wells Fargo

Edwards Lifesciences price target raised to $96 from $95 at Wells Fargo

Target:$96.00

+11.9%from $85.78

Dec 5, 2025Stifel Nicolaus

Edwards Lifesciences (EW) PT Raised to $100 at Stifel

Target:$100.00

+16.6%from $85.78

Dec 5, 2025Truist Financial

Edwards Lifesciences (EW) PT Raised to $92 at Truist Securities

Target:$92.00

+7.3%from $85.78

Dec 4, 2025BTIG

Edwards Lifesciences price target raised to $103 from $100 at BTIG

Target:$103.00

+20.1%from $85.78

Nov 3, 2025Bernstein

Edwards Lifesciences (EW) PT Raised to $90 at Bernstein After a 'Strong Beat'

Target:$90.00

+9.2%from $82.45

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance